March 9 (Reuters) - Vertex Pharmaceuticals said on Monday that its experimental kidney disease drug met the main goal of a ...

By Kamal Choudhury March 9 (Reuters) - Vertex Pharmaceuticals said on Monday that its experimental drug sharply reduced a key sign of kidney damage in a late‑stage trial, putting the company on track ...

Vertex Pharmaceuticals Inc. shares rose as much as 11 percent in late trading Monday after the biotech company said its drug to treat a kidney disorder met its goal in a late-stage trial, providing a ...

Vertex said a drug it secured as part of a $4.9 billion acquisition successfully reduced by half a key marker of a kidney disease known as IgA nephropathy.

Company shares surged in after-market trading on results for a drug Vertex acquired in a multibillion-dollar deal and sees as ...

Vertex stock popped late Monday on promising test results for a drug that could treat a chronic autoimmune disease that ...

First new drug in 30 years to slow kidney disease in type 1 diabetes ...

Add Yahoo as a preferred source to see more of our stories on Google. The drug finerenone, made by pharma giant Bayer and marketed under the brand name Kerendia, was found to be effective in treating ...

Patients with a particular histopathologic phenotype may respond less well to rituximab, but it is still unclear what factors ...

aProximate TM PTCs maintain high expression of key transporters involved in drug handling, including megalin and cubilin, making them ideal for studying drug transporters and drug interactions with ...

Premature ovarian insufficiency (POI) is a clinically significant cause of infertility that affects between 1 to 3% of women of childbearing age. Symptoms include absent menses, low estrogen levels, ...

NEW YORK (Reuters Health) - People with failing kidneys may frequently use "natural" or homeopathic products and over-the-counter medications that could worsen their kidney function, a new study shows ...